Excerpt from: Market Watch (click for full article)
Omnicare, Inc. and WellCare Health Plans, Inc. announced today an agreement to provide Medication Therapy Management (MTM) services to WellCare beneficiaries residing in long-term care (LTC) facilities to improve health outcomes.
The Affordable Care Act requires prescription drug plan sponsors to offer MTM services to eligible beneficiaries that include, at a minimum, an annual Comprehensive Medication Review (CMR) that must be furnished person-to-person or using telehealth technologies. The CMR must include a review of the beneficiary's medications, which may result in the creation of a medication action plan with a written or printed summary of the results of the review provided to the targeted beneficiary. Beginning January 1, 2013, the offer of the CMR to all eligible beneficiaries includes enrollees who are in the LTC setting.
"Omnicare is pleased to work with WellCare to improve its beneficiaries' drug therapy outcomes," said Dr. Gary Erwin, Omnicare Senior Vice President of Clinical Services. "Omnicare's clinical pharmacists are experts in geriatric care with a detailed knowledge of beneficiary clinical status, existing treatment goals and care plans. Through their experience, and with Omnicare's proprietary clinical software, the Omnicare clinical pharmacist coordinates the drug regimen review and CMR processes, engaging beneficiaries and prescribers in the LTC setting to implement quality-based drug therapy recommendations in a seamless and efficient manner."
Comments